Drugs / Bioarginine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04626375 Comparator | Sep 2020 → Aug 2021 | myocardial disorder | Federico II University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bioarginine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04626375 ↗ |
| Route | Oral | “2 vials per os of 1.66 g every 12 hours” NCT04626375 ↗ |